Biomark Diagnostics Inc. (CSE:BUX)
Canada
· Delayed Price · Currency is CAD 0.3000
0.00 (0.00%)
May 30, 2025, 12:47 PM EDT
Biomark Diagnostics Revenue
Biomark Diagnostics had revenue of 38.56K CAD in the quarter ending December 31, 2024, a decrease of -7.17%. This brings the company's revenue in the last twelve months to 155.03K, down -4.98% year-over-year. In the fiscal year ending March 31, 2024, Biomark Diagnostics had annual revenue of 163.22K with 6.34% growth.
Revenue (ttm)
155.03K
Revenue Growth
-4.98%
P/S Ratio
180.93
Revenue / Employee
n/a
Employees
n/a
Market Cap
28.05M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Trulieve Cannabis | 1.71B |
| dentalcorp Holdings | 1.58B |
| Sienna Senior Living | 896.45M |
| Green Thumb Industries | 1.64B |
| Extendicare | 1.47B |
| Cronos Group | 179.08M |
| WELL Health Technologies | 990.34M |
| Curaleaf Holdings | 1.89B |